GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuPharma PLC (STU:25I) » Definitions » Other Stockholders Equity

ImmuPharma (STU:25I) Other Stockholders Equity : €6.96 Mil (As of Jun. 2023)


View and export this data going back to 2012. Start your Free Trial

What is ImmuPharma Other Stockholders Equity?

ImmuPharma's Other Stockholders Equity for the quarter that ended in Jun. 2023 was €6.96 Mil.

ImmuPharma's quarterly Other Stockholders Equity declined from Jun. 2022 (€36.11 Mil) to Dec. 2022 (€6.75 Mil) but then increased from Dec. 2022 (€6.75 Mil) to Jun. 2023 (€6.96 Mil).

ImmuPharma's annual Other Stockholders Equity increased from Dec. 2020 (€3.72 Mil) to Dec. 2021 (€6.19 Mil) and increased from Dec. 2021 (€6.19 Mil) to Dec. 2022 (€6.75 Mil).


ImmuPharma Other Stockholders Equity Historical Data

The historical data trend for ImmuPharma's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuPharma Other Stockholders Equity Chart

ImmuPharma Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.99 1.81 3.72 6.19 6.75

ImmuPharma Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.23 6.19 36.11 6.75 6.96

ImmuPharma Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


ImmuPharma Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of ImmuPharma's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


ImmuPharma (STU:25I) Business Description

Traded in Other Exchanges
Address
One Bartholomew Close, London, GBR, EC1A 7BL
ImmuPharma PLC is a drug discovery and development company. The pipeline of the company includes novel peptide-based therapeutics within two therapy areas: autoimmunity & inflammation, and anti-infectives. The company's drug candidate is Lupuzor, which treats lupus and a life-threatening autoimmune disease.

ImmuPharma (STU:25I) Headlines

No Headlines